Martin K J, Hruska K A, Lewis J, Anderson C, Slatopolsky E
J Clin Invest. 1977 Oct;60(4):808-14. doi: 10.1172/JCI108834.
The mechanisms of uptake of parathyroid hormone (PTH) by the kidney was studied in anesthetized dogs before and after ureteral ligation. During constant infusion of bovine PTH (b-PTH 1-84), the renal arteriovenous (A-V) difference for immunoreactive PTH (i-PTH) was 22+/-2%. After ureteral ligation and no change in renal plasma flow, A-V i-PTH fell to 15+/-1% (P < 0.01), indicating continued and significant uptake of i-PTH at peritubular sites and a lesser role of glomerular filtration (GF) in the renal uptake of i-PTH. Since, under normal conditions, minimal i-PTH appears in the final urine, the contribution of GF and subsequent tubular reabsorption was further examined in isolated perfused dog kidneys before and after inhibition of tubular reabsorption by potassium cyanide. Urinary i-PTH per 100 ml GF rose from 8+/-4 ng/min (control) to 170+/-45 ng/min after potassium cyanide. Thus, i-PTH is normally filtered and reabsorbed by the tubular cells. The physiological role of these two mechanisms of renal PTH uptake was examined by giving single injections of b-PTH 1-84 or synthetic b-PTH 1-34 in the presence of established ureteral ligation. After injection of b-PTH 1-84, renal A-V i-PTH was 20% only while biologically active intact PTH was present (15-20 min). No peritubular uptake of carboxyl terminal PTH fragments was demonstrable. In contrast, after injection of synthetic b-PTH 1-34, renal extraction of N-terminal i-PTH after ureteral ligation (which was 13.4+/-0.6% vs. 19.6+/-0.9% in controls) continued for as long as i-PTH persisted in the circulation. These studies indicate that both GF and peritubular uptake are important mechanisms for renal PTH uptake. Renal uptake of carboxyl terminal fragments of PTH is dependent exclusively upon GF and tubular reabsorption, whereas peritubular uptake can only be demonstrated for biologically active b-PTH 1-84 and synthetic b-PTH 1-34.
在输尿管结扎前后,对麻醉犬甲状旁腺激素(PTH)的肾脏摄取机制进行了研究。在持续输注牛PTH(b-PTH 1-84)期间,免疫反应性PTH(i-PTH)的肾动静脉(A-V)差值为22±2%。输尿管结扎后且肾血浆流量无变化时,A-V i-PTH降至15±1%(P<0.01),表明i-PTH在肾小管周围部位持续且大量摄取,而肾小球滤过(GF)在i-PTH的肾脏摄取中作用较小。由于在正常情况下,最终尿液中出现的i-PTH极少,因此在通过氰化钾抑制肾小管重吸收前后,对离体灌注犬肾中GF及随后的肾小管重吸收作用进行了进一步研究。每100ml GF的尿i-PTH在氰化钾处理后从8±4ng/min(对照)升至170±45ng/min。因此,i-PTH通常由肾小管细胞滤过并重吸收。在已结扎输尿管的情况下,通过单次注射b-PTH 1-84或合成b-PTH 1-34,研究了这两种肾脏摄取PTH机制的生理作用。注射b-PTH 1-84后,仅在生物活性完整的PTH存在时(15 - 20分钟),肾A-V i-PTH为20%。未发现肾小管周围对羧基末端PTH片段的摄取。相反,注射合成b-PTH 1-34后,输尿管结扎后肾对N末端i-PTH的摄取(对照中为19.6±0.9%,结扎后为13.4±0.6%)只要i-PTH持续存在于循环中就会持续。这些研究表明,GF和肾小管周围摄取都是肾脏摄取PTH的重要机制。PTH羧基末端片段的肾脏摄取仅依赖于GF和肾小管重吸收,而肾小管周围摄取仅在生物活性b-PTH 1-84和合成b-PTH 1-34中得到证实。